Massachusetts Institute of Technology, Engineering Systems Division, 77 Massachusetts Avenue, 02139 Cambridge, MA, USA.
Int J Med Inform. 2013 May;82(5):345-58. doi: 10.1016/j.ijmedinf.2012.11.017. Epub 2012 Dec 28.
To reduce unnecessary lab testing by predicting when a proposed future lab test is likely to contribute information gain and thereby influence clinical management in patients with gastrointestinal bleeding. Recent studies have demonstrated that frequent laboratory testing does not necessarily relate to better outcomes.
Data preprocessing, feature selection, and classification were performed and an artificial intelligence tool, fuzzy modeling, was used to identify lab tests that do not contribute an information gain. There were 11 input variables in total. Ten of these were derived from bedside monitor trends heart rate, oxygen saturation, respiratory rate, temperature, blood pressure, and urine collections, as well as infusion products and transfusions. The final input variable was a previous value from one of the eight lab tests being predicted: calcium, PTT, hematocrit, fibrinogen, lactate, platelets, INR and hemoglobin. The outcome for each test was a binary framework defining whether a test result contributed information gain or not.
Predictive modeling was applied to recognize unnecessary lab tests in a real world ICU database extract comprising 746 patients with gastrointestinal bleeding.
Classification accuracy of necessary and unnecessary lab tests of greater than 80% was achieved for all eight lab tests. Sensitivity and specificity were satisfactory for all the outcomes. An average reduction of 50% of the lab tests was obtained. This is an improvement from previously reported similar studies with average performance 37% by [1-3].
Reducing frequent lab testing and the potential clinical and financial implications are an important issue in intensive care. In this work we present an artificial intelligence method to predict the benefit of proposed future laboratory tests. Using ICU data from 746 patients with gastrointestinal bleeding, and eleven measurements, we demonstrate high accuracy in predicting the likely information to be gained from proposed future lab testing for eight common GI related lab tests. Future work will explore applications of this approach to a range of underlying medical conditions and laboratory tests.
通过预测拟议的未来实验室检测何时可能提供信息增益,从而影响胃肠道出血患者的临床管理,减少不必要的实验室检测。最近的研究表明,频繁的实验室检测不一定与更好的结果相关。
进行了数据预处理、特征选择和分类,并使用人工智能工具模糊建模来识别不会提供信息增益的实验室检测。共有 11 个输入变量。其中 10 个变量来自床边监护仪趋势(心率、血氧饱和度、呼吸频率、体温、血压和尿液采集)以及输液产品和输血。最后一个输入变量是要预测的八个实验室检测之一的前一个值:钙、PTT、血细胞比容、纤维蛋白原、乳酸、血小板、INR 和血红蛋白。每个检测的结果是一个二进制框架,定义检测结果是否提供信息增益。
预测模型应用于识别胃肠道出血的真实 ICU 数据库中 746 例患者的不必要实验室检测。
对于所有 8 个实验室检测,必要和不必要实验室检测的分类准确率均超过 80%。所有结果的灵敏度和特异性均令人满意。平均减少了 50%的实验室检测。这比以前报道的类似研究(平均性能为 37%)[1-3]有了显著的改进。
减少频繁的实验室检测以及潜在的临床和财务影响是重症监护的一个重要问题。在这项工作中,我们提出了一种人工智能方法来预测拟议的未来实验室检测的获益。使用来自 746 例胃肠道出血患者的 ICU 数据和 11 项测量值,我们证明了在预测八个常见胃肠道相关实验室检测的未来检测中可能获得的信息方面具有很高的准确性。未来的工作将探索该方法在一系列潜在医学状况和实验室检测中的应用。